Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ABL-101
- Development stage
- Unknown
- Lead developer
- Aurum Biosciences
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
ABL-101 is a novel perfluorocarbon (PFC)-based oxygen carrier and diagnostic imaging agent being developed by Aurum Biosciences. It functions as a therapeutic by delivering oxygen to ischemic or traumatized tissues; its particles are significantly smaller than red blood cells, enabling them to bypass vascular blockages or traverse collateral vessels. Additionally, it serves as a diagnostic tool through Glasgow Oxygen Level Dependent (GOLD) technology, which enhances MRI imaging to detect tissue under metabolic stress or inflammation. Originally known as Oxycyte, ABL-101 is administered intravenously in combination with supplemental oxygen and is being investigated for conditions including acute ischemic stroke, spinal cord injury, and various inflammatory diseases.
- Other names
- Oxycyte
Beyond the preview
Go deeper on ABL-101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABL-101.